Spyre Therapeutics, Inc (SYRE) insider trading
Every open-market stock purchase and sale by Spyre Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Scott L Burrows (CFO) and 3 others sold $16.9M in the last 90 days.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $443M (31 sales). Last close $92.95 on Oct 21, 2026.
Recent SYRE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Heidy King-Jones (Officer) | Sold | $1.5M |
| Oct 1, 2026 | Heidy King-Jones (Officer) | Sold | $660K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $466K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $368K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Sold | $285K |
| Oct 1, 2026 | Heidy King-Jones (Officer) | Sold | $243K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $242K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $241K |
| Oct 1, 2026 | Heidy King-Jones (Officer) | Sold | $195K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Sold | $193K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Sold | $135K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $53.5K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Sold | $53.4K |
| Oct 1, 2026 | Heidy King-Jones (Officer) | Sold | $35.7K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Sold | $21.4K |
| Oct 1, 2026 | Cameron Turtle (CEO) | Sold | $9.4K |
| Oct 1, 2026 | Scott L Burrows (CFO) | Bought (not open market) | — |
| Oct 1, 2026 | Heidy King-Jones (Officer) | Bought (not open market) | — |
| Sep 30, 2026 | Scott L Burrows (CFO) | Sold | $1.6M |
| Sep 30, 2026 | Scott L Burrows (CFO) | Bought (not open market) | — |
| Sep 2, 2026 | Scott L Burrows (CFO) | Sold | $1.6M |
| Sep 2, 2026 | Heidy King-Jones (Officer) | Sold | $36K |
| Sep 2, 2026 | Heidy King-Jones (Officer) | Bought (not open market) | — |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Sold | $1.4M |
| Sep 1, 2026 | Cameron Turtle (CEO) | Sold | $732K |
Who's trading SYRE
- Heidy King-Jones, Officer: sold $5.1M (10 sales), last Oct 1, 2026
- Scott L Burrows, CFO: sold $9.1M (26 sales), last Oct 1, 2026
- Cameron Turtle, CEO: sold $11.4M (40 sales), last Oct 1, 2026
- Jeffrey W. Albers, Director: sold $2.4M (3 sales), last Aug 7, 2026
- Sheldon Sloan, C-suite exec: sold $7.4M (11 sales), last Jul 1, 2026
- Fairmount Funds Management LLC, Insider: sold $400M (1 sale), last Jun 23, 2026
- Michael Thomas Henderson, Director: sold $8M (5 sales), last Jun 22, 2026
- Mark C. McKenna, Director: other filings, last May 27, 2026
- Sandra Milligan, Director: other filings, last May 27, 2026
- Laurie Stelzer, Director: other filings, last May 27, 2026
Get free alerts when an insider at Spyre Therapeutics, Inc files a new trade →